Maureen Bisognano, Executive Vice President and Chief Operating Officer at the Institute for Healthcare Improvement, explores some of the theories of Dr. Noriaki Kano. In the healthcare industry the connections between quality and cost are not always clear. Mrs. Bisognano uses Dr. Kano's framework and demonstrates three ways that health care leaders can improve quality. She also speaks on the need to balance competing priorities and associated tensions between professionals of the healthcare and financial services respectively. Finally, Mrs. Bisognano describes new roles for physician leaders as they work to improve clinical and operational performance and achieve best financial outcomes.
The Kano Philosophy for Excellence in Health Care
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Maureen Bisognano, Executive Vice President and Chief Operating Officer at the Institute for Healthcare Improvement, explores some of the theories of Dr. Noriaki Kano. In the healthcare industry the connections between quality and cost are not always clear. Mrs. Bisognano uses Dr. Kano's framework and demonstrates three ways that health care leaders can improve quality. She also speaks on the need to balance competing priorities and associated tensions between professionals of the healthcare and financial services respectively. Finally, Mrs. Bisognano describes new roles for physician leaders as they work to improve clinical and operational performance and achieve best financial outcomes.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?